Healthcare
Friday, August 26, 2016
BRIEF-TG Therapeutics announces orphan drug designation for TG-1101
* TG Therapeutics announces orphan drug designation for
TG-1101 for the treatment of neuromyelitis optica and
neuromyelitis optica spectrum disorder
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment